Drug manufacturer Astellas will let 340B covered entities using “a compliant 340B inventory replenishment model” count accumulations of its antifungal Cresemba under its old National Drug Code toward replenishment of equal quantities under the product’s corresponding new NDC, the company
…
The Medicare Payment Advisory Commission, as expected, has voted to recommend that Congress should start phasing in a new way of distributing extra Medicare payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.
The proposal that
…
Ryan White Clinics for 340B Access is dropping its lawsuit that, together with a related case, led federal health officials to issue long-delayed dispute resolution rules for the 340B program in December 2020.
RWC-340B, five co-plaintiff 340B covered entities, and
…
A federal district court in South Carolina yesterday sealed the federal government’s records of the audit, expulsion, and reinstatement of a health center for allegedly diverting 340B-acquired drugs to ineligible patients.
The court order was in Genesis Health Care’s lawsuit
…
Annual recertification of 340B eligibility for federally qualified health centers and most other grantee-type entities will start Jan. 30 and end Feb. 27, the U.S. Health Resources and Services Administration said yesterday.
HRSA did not say when Title X family
…
U.S. Rep. Matt Rosendale (R-Mont.) has introduced legislation reportedly the same as he filed during the last session of Congress to impose conditions on hospital participation in the 340B program. More bills dealing with 340B are likely.
…
U.S. Rep. Cathy McMorris Rodgers (R-Wash.) announced Tuesday that she was named chair of the House Energy & Commerce Committee. She in turn announced yesterday that the House Republican Steering Committee recommended nine new members to serve on the panel.
…
The U.S. Centers for Medicare & Medicaid Services will publish the first 10 Medicare Part D drugs selected for the new Medicare Drug Price Negotiation Program by Sept. 1, CMS announced yesterday.
The negotiated maximum fair prices for these drugs
…
A federal district judge in Washington, D.C., this morning ruled that Medicare Part B underpayments to hospitals for 340B drugs from 2018 to 2022 were unlawful. But in a disappointment for the hospital groups that sued, the judge declined to
…
A federal district court in South Carolina ordered 340B Report late yesterday to destroy and not release information from more than 9,000 pages of documents that the federal government filed in a public database Thursday in a community health center’s
…*Sign up for news summaries and alerts from 340B Report